Gene · 406977
Papers1,599
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,599
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Naïve or Engineered Extracellular Vesicles from Different Cell Sources: Therapeutic Tools for Kidney Diseases. | Pharmaceutics | 2023 | 37376163 | PubTator, text mining | PubMed |
| Exploring the Potential Role of Circulating microRNAs as Biomarkers for Predicting Clinical Response to Neoadjuvant Therapy in Breast Cancer. | Int J Mol Sci | 2023 | 37373139 | PubTator, text mining | PubMed |
| MicroRNAs as Potential Biomarkers in Gynecological Cancers. | Biomedicines | 2023 | 37371799 | PubTator, text mining | PubMed |
| MiRNA-Based Therapies for Lung Cancer: Opportunities and Challenges? | Biomolecules | 2023 | 37371458 | PubTator, text mining | PubMed |
| A validated model for individualized prediction of pregnancy outcome in woman after fresh cycle of Day 5 single blastocyst transfer. | Sci Rep | 2023 | 37340007 | PubTator, text mining | PubMed |
| Identification of miR-143-3p as a diagnostic biomarker in gastric cancer. | BMC Med Genomics | 2023 | 37328880 | PubTator, text mining | PubMed |
| Non-coding RNA-mediated epigenetic alterations in Grave's ophthalmopathy: A scoping systematic review. | Noncoding RNA Res | 2023 | 37324526 | PubTator, text mining | PubMed |
| Epigenetics of the Pathogenesis and Complications of Type 2 Diabetes Mellitus. | touchREV Endocrinol | 2023 | 37313245 | PubTator, text mining | PubMed |
| Sodium tanshinone IIA sulphate inhibits angiogenesis in lung adenocarcinoma via mediation of miR-874/eEF-2K/TG2 axis. | Pharm Biol | 2023 | 37300283 | PubTator, text mining | PubMed |
| Potential Therapeutic Targets of Formononetin, a Type of Methoxylated Isoflavone, and Its Role in Cancer Therapy through the Modulation of Signal Transduction Pathways. | Int J Mol Sci | 2023 | 37298670 | PubTator, text mining | PubMed |
| Influence of Estrus on Dairy Cow Milk Exosomal miRNAs and Their Role in Hormone Secretion by Granulosa Cells. | Int J Mol Sci | 2023 | 37298559 | PubTator, text mining | PubMed |
| In-silico engineering of RNA nanoplatforms to promote the diabetic wound healing. | BMC Chem | 2023 | 37291669 | PubTator, text mining | PubMed |
| Current and prospective strategies for advancing the targeted delivery of CRISPR/Cas system via extracellular vesicles. | J Nanobiotechnology | 2023 | 37291577 | PubTator, text mining | PubMed |
| Current Status and Prospect of Delivery Vehicle Based on Mesenchymal Stem Cell-Derived Exosomes in Liver Diseases. | Int J Nanomedicine | 2023 | 37283714 | PubTator, text mining | PubMed |
| Genome-wide profiling of miRNA-gene regulatory networks in mouse postnatal heart development-implications for cardiac regeneration. | Front Cardiovasc Med | 2023 | 37283582 | PubTator, text mining | PubMed |
| Prevascularization techniques for dental pulp regeneration: potential cell sources, intercellular communication and construction strategies. | Front Bioeng Biotechnol | 2023 | 37274160 | PubTator, text mining | PubMed |
MiRNA dysregulation underlying common pathways in type 2 diabetes and cancer development: an Italian Association of Medical Oncology (AIOM)/Italian Association of Medical Diabetologists (AMD)/Italian Society of Diabetology (SID)/Italian Society of Endocrinology (SIE)/Italian Society of Pharmacology (SIF) multidisciplinary critical view. | ESMO Open | 2023 | 37263082 | PubTator, text mining | PubMed |
| Long-term outcomes and potential mechanisms of offspring exposed to intrauterine hyperglycemia. | Front Nutr | 2023 | 37255932 | PubTator, text mining | PubMed |
| miRNAs' Cross-Involvement in Skin Allergies: A New Horizon for the Pathogenesis, Diagnosis and Therapy of Atopic Dermatitis, Allergic Contact Dermatitis and Chronic Spontaneous Urticaria. | Biomedicines | 2023 | 37238937 | PubTator, text mining | PubMed |
| Extracellular Vesicles as Potential Therapeutic Messengers in Cancer Management. | Biology (Basel) | 2023 | 37237479 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/406977/papers?page=8